Pathogenesis of Glaucomatous Optic Nerve Damage

$596,589R01FY2010EYNIH

Johns Hopkins University, Baltimore MD

Investigators

Linked publications & trials

Paper 39565302 Paper 38560276 Paper 38272391 Paper 38110030 Paper 38088825 Paper 37762022 Paper 37382629 Paper 36993314 Paper 36476399 Paper 35863747 Paper 35196555 Paper 33529207 Paper 33502460 Paper 33382979 Paper 32910133 Paper 32353427 Paper 32343781 Paper 32179077 Paper 31279161 Paper 31157833 Paper 30578592 Paper 30479877 Paper 30372742 Paper 30025126 Paper 29625080 Paper 29616152 Paper 28549091 Paper 28414059 Paper 28146237 Paper 28108378 Paper 27955999 Paper 27358279 Paper 27336794 Paper 26900327 Paper 26811145 Paper 26505191 Paper 26161963 Paper 25751456 Paper 25714753 Paper 25531905 Paper 25448352 Paper 25285424 Paper 25228540 Paper 24832392 Paper 24557355 Paper 24368172 Paper 24146537 Paper 23535950 Paper 23431148 Paper 23404116 Paper 23369761 Paper 23188256 Paper 22786908 Paper 22701298 Paper 22589442 Paper 22554836 Paper 22395883 Paper 22210127 Paper 20868685 Paper 20811062 Paper 20720229 Paper 20599961 Paper 20091782 Paper 19878757 Paper 19853602 Paper 19060281 Paper 18543272 Paper 18199485 Paper 18055803 Paper 17106364 Paper 16769839 Paper 16546168 Paper 16123418 Paper 15862173 Paper 15728544 Paper 15534593 Paper 15111596 Paper 15097254 Paper 14534031 Paper 14507880 Paper 12882786 Paper 12413426 Paper 12362078 Paper 12091422 Paper 11923249 Paper 11818384 Paper 11545640 Paper 11274074 Paper 11006239 Paper 10711692 Paper 10711689

Abstract

To reduce the project to a 2 year proposal, I have retained the overall theme which is to study the effect of connective tissues of the sclera and peripapillary nerve head on axonal injury and RGC death. The portions of the 5 year proposal that were eliminated were much of former Aim 2 and 3 which dealt with studies of nerve head capillary function, and the roles of endothelin and tumor necrosis factor _ in RGC injury. We expect to test the role of connective tissue alteration in the ultimate survival of RGC in chronic experimental glaucoma (former Aim 4, now Aim 3), including the effect of chemical scleral cross-linking. To complete the project in 2 years, we eliminated from the 5 year proposal Hypotheses 7, 8, 9, and 11.

View original record on NIH RePORTER →